Stephen L. Sabba, Director at LIGAND PHARMACEUTICALS INC (LGND), sold 2,034 shares at $201.50 ($410K) on 2026-03-03, disclosed to the SEC on 2026-03-05.
Open-market sale of $410k LGND by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| LGND | SELL | 2024-03-07 | $281K | — | Filing → |
| LGND | SELL | 2023-05-12 | $988K | — | Filing → |
| LGND | SELL | 2021-02-11 | $6.0M | — | Filing → |